Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies
- This event has passed.
Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies
Speakers: Naiem T. Issa, MD, PhD, FAAD Dermatologist and Drug Discovery Researcher Assistant Professor of Dermatology, University of Miami School of Medicine George Washington University School of Medicine and Health Sciences Vienna, Virginia and Mona Shahriari, MD, FAAD Associate Clinical Professor of Dermatology, Yale University School of Medicine Co-Founder/Partner, Central Connecticut Dermatology Associate Director of Clinical Trials, CCD Research, Central Connecticut Dermatology
Moderator: Leon Kircik, MD, FAAD Medical Director, International Dermatology Foundation Clinical Professor of Dermatology Icahn School of Medicine at Mount Sinai, New York, NY Indiana University Medical Center, Indianapolis, IN Medical Director, Physicians Skin Care, PLLC, Louisville, KY, DermResearch, PLLC, Louisville, KY, Skin Sciences, PLLC, Louisville, KY
Please join us for our next IDF Educational Series Webinar: Advancing Care in Moderate-to-Severe Atopic Dermatitis: Disease Insights and Emerging Targeted Therapies Part 1: Deeper Understanding of Atopic Dermatitis This educational webinar will provide an overview of moderate-to-severe atopic dermatitis as a chronic, relapsing inflammatory disease driven by type 2 immune dysregulation and skin barrier dysfunction. Naiem T. Issa, MD, PhD, FAAD will review its clinical presentation, disease burden, impact on quality of life, and current management challenges to support informed clinical decision-making. Part 2: Explore EBGLYSS®(lebrikizumab-lbkz) Join us for “Explore EBGLYSS® (lebrikizumab-lbkz)”, an event where Mona Shahriari, MD, FAAD will discuss the efficacy and safety of EBGLYSS. This program features early and long-term data, safety, dosing information, and how to get patients started on EBGLYSS.